Study of pharmaceutical interventions in the anesthesia and intensive care department of Habib Thameur Hospital in Tunis and their clinical and economic impacts (notice n° 179005)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02070cam a2200229 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250112041121.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Chedly, Meriem |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Study of pharmaceutical interventions in the anesthesia and intensive care department of Habib Thameur Hospital in Tunis and their clinical and economic impacts |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2024.<br/> |
500 ## - GENERAL NOTE | |
General note | 48 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | IntroductionThe analysis of medical prescriptions and the development of pharmaceutical interventions (IP) is essential in resolving problems related to drug therapy. The objective of this study is to optimize patient care by evaluating the activity of clinical pharmacy in a given department.MethodsA cross-sectional study was carried out over a period of 6 months (in 2021) in the anesthesia and intensive care department. The pharmaceutical interventions (PI) were recorded on the data collection form of the French Society of Clinical Pharmacy. The clinical and economic impact was assessed using the CLEO scale.ResultsA total of 77 PIs were made. The acceptance rate was 94.8%. Dosage errors were the most commonly identified issue (50.6%), thus dosage adjustment was the most frequently recommended PI (49.3%). This resulted in direct cost savings of 97.762 TND (€29). The majority of PIs carried out had a clinical impact on the patient, with an average clinical impact of 37.96%.ConclusionWhile the pharmaceutical analysis of prescriptions optimizes the patient’s medication management, it must be supplemented by medication reconciliation and therapeutic education in order to guarantee better patient care. |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Akermi, Soumaya |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chaabane, Khadija Ben |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ellouze, Ibtihel |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Meksi, Eya |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fadhel, Kamel Ben |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mbarka, Fatma Ben |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Journal de Pharmacie Clinique | 43 | 2 | 2024-04-09 | p. 59-66 | 0291-1981 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-journal-de-pharmacie-clinique-2024-2-page-59?lang=en">https://shs.cairn.info/journal-journal-de-pharmacie-clinique-2024-2-page-59?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux